Loading
NP
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) Stock: price and insider trades · Canada
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare): what insiders have been doing
This page follows insider dealings at Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) as filed with SEDI. Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) has had no insider filing for more than a year; the last one goes back to 2 April 2022.
Since 2021, the database holds 14 purchases and no sales by insiders of the company.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
15
Thresholds
n/a
Buy Volume
€53,858
14 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 2 April 2022
Declarations15 total
6,800 shares@ CA$1.466726.3% of flowCommon SharesTSXSEDI:3921024
Canonical exit: 29 Jun 2022 (T+90)
2,700 shares@ CA$1.44613.2% of flowCommon SharesTSXSEDI:3766360
Canonical exit: 20 Sept 2021 (T+90)
3,000 shares@ CA$1.45100.0% of flowCommon SharesTSXSEDI:3766364
Canonical exit: 19 Sept 2021 (T+90)
2,200 shares@ CA$1.46310.9% of flowCommon SharesTSXSEDI:3766362
Canonical exit: 21 Sept 2021 (T+90)
Common SharesTSXSEDI:3766363
2,000 shares@ CA$1.43559.7% of flowCommon SharesTSXSEDI:3765576
Canonical exit: 19 Sept 2021 (T+90)
1,155 shares@ CA$1.4921.0% of flowCommon SharesTSXSEDI:3761452
Canonical exit: 8 Sept 2021 (T+90)
600 shares@ CA$1.4510.6% of flowCommon SharesTSXSEDI:3761451
Canonical exit: 8 Sept 2021 (T+90)
700 shares@ CA$1.3911.9% of flowCommon SharesTSXSEDI:3761449
Canonical exit: 8 Sept 2021 (T+90)
3,300 shares@ CA$1.4056.5% of flowCommon SharesTSXSEDI:3761450
Canonical exit: 8 Sept 2021 (T+90)
6,000 shares@ CA$1.4532.9% of flowCommon SharesTSXSEDI:3752463
Canonical exit: 26 Aug 2021 (T+90)
1,181 shares@ CA$1.506.7% of flowCommon SharesTSXSEDI:3751532
Canonical exit: 24 Aug 2021 (T+90)
10,000 shares@ CA$1.601560.4% of flowCommon SharesTSXSEDI:3748231
Canonical exit: 18 Aug 2021 (T+90)
4,700 shares@ CA$1.670226.1% of flowCommon SharesTSXSEDI:3710963
Canonical exit: 20 Jun 2021 (T+90)
6,500 shares@ CA$1.855740.2% of flowCommon SharesTSXSEDI:3708035
Canonical exit: 14 Jun 2021 (T+90)
15 of 15 declarations
About Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)
Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, is a company focused on the development and commercialization of pharmaceutical products. It aims to provide therapeutic solutions to enhance patients' quality of life.
